pancratistatin has been researched along with etoposide in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kekre, N; McLachlan, A; McNulty, J; Pandey, S | 1 |
Kekre, N; McNulty, J; Naderi, J; Pandey, S | 1 |
2 other study(ies) available for pancratistatin and etoposide
Article | Year |
---|---|
Pancratistatin: a natural anti-cancer compound that targets mitochondria specifically in cancer cells to induce apoptosis.
Topics: Amaryllidaceae Alkaloids; Antineoplastic Agents, Phytogenic; Apoptosis; Caspase 3; Caspases; Cells, Cultured; Etoposide; Fibroblasts; Humans; Intracellular Membranes; Isoquinolines; Mitochondria; Neuroblastoma; Paclitaxel; Permeability; Proteasome Endopeptidase Complex; Reactive Oxygen Species; Tumor Cells, Cultured | 2005 |
Induction of apoptotic cell death specifically in rat and human cancer cells by pancratistatin.
Topics: Amaryllidaceae Alkaloids; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Dose-Response Relationship, Drug; Etoposide; Fibroblasts; Humans; Isoquinolines; Neoplasms; Paclitaxel; Rats | 2005 |